Cargando…

Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features

Upper urinary tract urothelial carcinoma (UT-UC) is rare and treatment options or prognostic markers are limited. There is increasing evidence indicating that urothelial carcinoma may be an endocrine-related cancer. The aim of this study was to analyze the prognostic effect of estrogen receptor beta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Hao Lun, Sung, Ming Tse, Tsai, Eing Mei, Lin, Chang Shen, Lee, Nai Lun, Chung, Yueh-Hua, Chiang, Po Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823660/ https://www.ncbi.nlm.nih.gov/pubmed/27052470 http://dx.doi.org/10.1038/srep24263

Ejemplares similares

Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2019)

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway
por: Chen, I-Hsuan, et al.
Publicado: (2019)

Does preoperative percutaneous nephrostomy insertion worsen upper-tract urothelial cancer oncological outcome? A retrospective single center study
por: Huang, Guan-Lin, et al.
Publicado: (2019)

The Prognostic Impact of Tumor Location in pT3N0M0 Upper Urinary Tract Urothelial Carcinoma: A Retrospective Cohort Study
por: Chen, Tzu Shuang, et al.
Publicado: (2022)

The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
por: Chang, Yin Lun, et al.
Publicado: (2023)

Propensity-Matched Survival Analysis of Upper Urinary Tract Urothelial Carcinomas between End-Stage Renal Disease with and without Kidney Transplantation
por: Luo, Hao Lun, et al.
Publicado: (2019)

VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2023)

Comparison of the Prognostic Value of Ki-67 and Programmed Cell Death Ligand-1 in Patients with Upper Tract Urothelial Carcinoma
por: Tsai, Mu-Yao, et al.
Publicado: (2021)

The Prognostic Impact of Tumor Architecture for Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Weighted Analysis
por: Liu, Hui-Ying, et al.
Publicado: (2021)

Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2021)

Clinical Determinants of Extraurinary Tract Recurrence and Survival after Radical Surgery for pT2 Upper Tract Urothelial Carcinoma
por: Huang, Yun-Ching, et al.
Publicado: (2023)

Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival
por: Su, Yu-Li, et al.
Publicado: (2020)

AB113. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2015)

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2016)

The lowest level of tumor involvement is a significant prognostic factor for upper tract urothelial carcinoma after radical nephroureterectomy: A large retrospective cohort study
por: Huang, Ying-Che, et al.
Publicado: (2022)

Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma
por: Kim, Tae Heon, et al.
Publicado: (2021)

Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Yuan, Changwei, et al.
Publicado: (2023)

Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma
por: Park, Bong Hee, et al.
Publicado: (2013)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023)

MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells
por: Chung, Yueh-Hua, et al.
Publicado: (2017)

DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma
por: Kao, Chien-Chang, et al.
Publicado: (2022)

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma
por: Horiguchi, Hirotaka, et al.
Publicado: (2018)

Oncological impact of different distal ureter managements during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma
por: Lai, Shi-Cong, et al.
Publicado: (2020)

Clinicopathological Significance of Estrogen Receptor β and Estrogen Synthesizing/Metabolizing Enzymes in Urothelial Carcinoma of Urinary Bladder
por: Sato, Naomi, et al.
Publicado: (2021)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Time to change the management of upper urinary tract urothelial carcinoma
por: Akand, Murat, et al.
Publicado: (2020)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
por: Grobet-Jeandin, Elisabeth, et al.
Publicado: (2021)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con
por: Seles, Maximilian, et al.
Publicado: (2021)

Hypercalcemia an exceptional complication in upper urinary tract urothelial carcinoma
por: Jandou, Issam, et al.
Publicado: (2021)

Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma
por: Lin, Deng, et al.
Publicado: (2022)

Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group
por: Lin, Chung-Yu, et al.
Publicado: (2022)

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022)

The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma
por: Zhang, Xiaodi, et al.
Publicado: (2021)

Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan
por: Chen, I-Hsuan Alan, et al.
Publicado: (2022)

Prognostic factors in laser treatment of upper urinary tract urothelial tumours
por: Niţă, Gh, et al.
Publicado: (2012)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
por: Smentkowski, Katherine E., et al.
Publicado: (2020)

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma
por: Kodama, Hirotake, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gb8eon65ttmu0ppt5j9dnqc6l9